MARÍA JOSÉ
SÁNCHEZ PÉREZ
DOCENTE INVITADA
Hospital Universitario San Cecilio
Granada, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario San Cecilio (16)
2023
-
Epidemiology of human papillomavirus-associated anogenital cancers in Granada: a three-decade population-based study
Frontiers in Public Health, Vol. 11
-
Health-related quality of life in patients newly diagnosed with prostate cancer: CAPLIFE study
Quality of Life Research, Vol. 32, Núm. 4, pp. 977-988
2022
-
Dietary Patterns and Prostate Cancer: CAPLIFE Study
Cancers, Vol. 14, Núm. 14
-
Salivary Melatonin Rhythm and Prostate Cancer: CAPLIFE Study
Journal of Urology, Vol. 207, Núm. 3, pp. 565-572
2020
-
Compliance with the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and Prostate Cancer
Nutrients, Vol. 12, Núm. 3
-
Compliance with the 2018 world cancer research fund/American institute for cancer research cancer prevention recommendations and prostate cancer
Nutrients, Vol. 12, Núm. 3
-
Night shift work, chronotype, sleep duration, and prostate cancer risk: Caplife study
International Journal of Environmental Research and Public Health, Vol. 17, Núm. 17, pp. 1-17
-
The effect of an online exercise programme on bone health in paediatric cancer survivors (iBoneFIT): Study protocol of a multi-centre randomized controlled trial
BMC Public Health, Vol. 20, Núm. 1
2019
-
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Scientific Reports, Vol. 9, Núm. 1
2017
-
Costs associated with influenza-related hospitalization in the elderly
Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416
2016
-
Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases
Oncology Letters, Vol. 12, Núm. 5, pp. 3127-3134
2015
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
2014
-
Disease-free survival related factors in breast cancer
Medicina Clinica, Vol. 143, Núm. 7, pp. 293-299
2013
-
Prevalencia de obesidad infantil y juvenil en España en 2012
Revista Espanola de Cardiologia, Vol. 66, Núm. 5, pp. 371-376
-
Risk of second primary cancer among women with breast cancer: A population-based study in Granada (Spain)
Gynecologic Oncology, Vol. 130, Núm. 2, pp. 340-345
2009
-
Plasmacytoid lymphoma treated with rituximab as fi rst-line monotherapy
Clinical and Translational Oncology